elisidepsin
Small moleculeexperimental
Clinical trial activity
2 trials · 5 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Aug 1, 2005 (NCT00404521)
Timeline
2000s
- Jan 1, 2005
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Unspecified targetUnclear
unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- elisidepsin
- irvalec
- pm02734
- pm02734
- pm02734
- pm02734
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00884845 | Phase 1 | Jan 1, 2009 | Badalona Hospital Germans Trias i Pujol, PharmaMar, Universidad Autonoma de Barcelona, Yeshiva University |
| NCT00404521 | Phase 1 | Aug 1, 2005 | PharmaMar, University of Chicago |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (5)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| PharmaMar | For profit | 2 | 2 | 1 | 2005 |
| Badalona Hospital Germans Trias i Pujol | Academic/Hospital | 1 | 0 | 1 | 2009 |
| Universidad Autonoma de Barcelona | Academic/Hospital | 1 | 0 | 1 | 2009 |
| University of Chicago | Academic/Hospital | 1 | 0 | 1 | 2005 |
| Yeshiva University | Academic/Hospital | 1 | 0 | 1 | 2009 |
5 organizations
Page 1 / 1